BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25124595)

  • 21. The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects.
    González-Castro TB; Hernández-Díaz Y; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Fresan A
    Neuromolecular Med; 2016 Jun; 18(2):216-31. PubMed ID: 27020768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of COMT Val158Met polymorphism in Eastern UP population.
    Kumar P; Yadav U; Rai V
    Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):21-24. PubMed ID: 28968204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis.
    Su M; Song Y
    Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catechol-O-methyltransferase Val158Met polymorphism is associated with pain and disability, but not widespread pressure pain sensitivity, in women with carpal Tunnel syndrome.
    Fernández-de-las-Peñas C; Ambite-Quesada S; Ortega-Santiago R; Martínez-Perez A; Díaz HF; Martínez-Martín J; Parejam JA
    Pain Physician; 2013; 16(5):E591-600. PubMed ID: 24077209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catechol-O-Methyltransferase (COMT) rs4680 Val158Met Polymorphism is Associated With Widespread Pressure Pain Sensitivity and Depression in Women With Chronic, but not Episodic, Tension-Type Headache.
    Fernández-de-Las-Peñas C; Ambite-Quesada S; Palacios-Ceña M; Guillem-Mesado A; Guerrero-Peral Á; Pareja JA; Arendt-Nielsen L
    Clin J Pain; 2019 Apr; 35(4):345-352. PubMed ID: 30614828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
    Qin X; Peng Q; Qin A; Chen Z; Lin L; Deng Y; Xie L; Xu J; Li H; Li T; Li S; Zhao J
    Diagn Pathol; 2012 Oct; 7():136. PubMed ID: 23039364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.
    Zhang H; Zhang Z; Wu J; Xu Y; Cheng R; Li L
    Urol Int; 2013; 91(2):213-9. PubMed ID: 23257985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
    Tan X; Chen M
    Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for
    Dzhemlikhanova LK; Efimova OA; Osinovskaya NS; Parfenyev SE; Niauri DA; Sultanov IY; Malysheva OV; Pendina AA; Shved NY; Ivashchenko TE; Yarmolinskaya MI; Kakhiani MI; Gorovaya EA; Tkachenko AN; Baranov VS
    J Clin Pathol; 2017 Mar; 70(3):233-236. PubMed ID: 27491313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome.
    Fernández-de-Las-Peñas C; Ambite-Quesada S; Gil-Crujera A; Cigarán-Méndez M; Peñacoba-Puente C
    J Pain; 2012 Nov; 13(11):1068-74. PubMed ID: 23025981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
    Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
    Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
    Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
    Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Val158Met polymorphism in COMT gene with attention-deficit hyperactive disorder: An updated meta-analysis.
    Kang P; Luo L; Peng X; Wang Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23400. PubMed ID: 33235119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic contribution of catechol-O-methyltransferase polymorphism (Val158Met) in children with chronic tension-type headache.
    Fernández-de-las-Peñas C; Ambite-Quesada S; Rivas-Martínez I; Ortega-Santiago R; de-la-Llave-Rincón AI; Fernández-Mayoralas DM; Pareja JA
    Pediatr Res; 2011 Oct; 70(4):395-9. PubMed ID: 21691248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
    Goodman JE; Lavigne JA; Hengstler JG; Tanner B; Helzlsouer KJ; Yager JD
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1373-6. PubMed ID: 11142424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia.
    Desmeules J; Chabert J; Rebsamen M; Rapiti E; Piguet V; Besson M; Dayer P; Cedraschi C
    J Pain; 2014 Feb; 15(2):129-35. PubMed ID: 24342707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan.
    Hamajima N; Matsuo K; Tajima K; Mizutani M; Iwata H; Iwase T; Miura S; Oya H; Obata Y
    Int J Clin Oncol; 2001 Feb; 6(1):13-8. PubMed ID: 11706521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria.
    Lajin B; Hamzeh AR; Ghabreau L; Mohamed A; Al Moustafa AE; Alachkar A
    Breast Cancer; 2013 Jan; 20(1):62-6. PubMed ID: 22124994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.
    Giakoumaki SG; Roussos P; Bitsios P
    Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.